Literature DB >> 6699649

Sialic acid and fatty acid concentrations in lymphocytes, red blood cells and plasma from patients with multiple sclerosis.

G D Cherayil.   

Abstract

Lipids and constituents of lipids were isolated from peripheral blood lymphocytes (PBL), red blood cells (RBC), plasma and sera from 51 patients with multiple sclerosis (MS) and 51 controls, matched for age, sex and race. The amount of sialic acid released by incubation of intact PBL from MS patients was significantly lower (P less than 0.02) than that of the sialic acid from control lymphocytes. The amounts of sialic acid released by neuraminidase from intact RBC, on the other hand, did not differ significantly between the MS group and the control group. The concentrations of ganglioside sialic acid in PBL from MS and control groups did not vary significantly. Similarly the concentration of ganglioside sialic acid in RBC from MS patients was not significantly different from that in the controls. Analyses of the fatty acids isolated after alkaline methanolysis of the lipids from the PBL of MS patients and controls showed a small but significant decrease (P less than 0.01) in the relative percentage of linoleic acid in patients with MS. Determination of the ester-linked fatty acids in RBC lipids from patients with MS showed a significant decrease (P less than 0.001) in the relative percentage of linoleic acid and an increase (P less than 0.01) in palmitic plus palmitoleic acids compared to control values. The fatty acid composition of the plasma neutral lipids plus free fatty acids showed a very significant decrease (P much less than 0.001) in the relative percentage of linoleic acid, a small decrease (P less than 0.05) in arachidonic acid and significant increases in palmitic (P less than 0.001) and oleic acids (P less than 0.001) in MS, compared to controls. These results are suggestive of possible differences in metabolism of lipids between patients with MS and controls.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699649     DOI: 10.1016/0022-510x(84)90104-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

1.  Monounsaturated fatty acids in blood cell membranes from patients with multiple sclerosis.

Authors:  Gloudina Maria Hon; Mogamat Shafick Hassan; Susan Janse van Rensburg; Stefan Abel; Rajiv T Erasmus; Tandi Matsha
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

2.  Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis.

Authors:  T Nishida; H Miwa; A Shigematsu; M Yamamoto; M Iida; M Fujishima
Journal:  Gut       Date:  1987-08       Impact factor: 23.059

3.  Erythrocyte membrane fatty acids in multiple sclerosis patients and hot-nature dietary intervention with co-supplemented hemp-seed and evening-primrose oils.

Authors:  Soheila Rezapour-Firouzi; Seyed Rafie Arefhosseini; Mehrangiz Ebrahimi-Mamaghani; Mehdi Farhoudi; Behzad Baradaran; Torbati Mohammad Ali; Fatemeh Zamani
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-10-03

4.  Fatty acid content in lymphocytes from children with syndromic paucity of interlobular bile ducts, Alagille syndrome.

Authors:  P Pina; M Couturier; F Lemonnier
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis.

Authors:  D Bates; N E Cartlidge; J M French; M J Jackson; S Nightingale; D A Shaw; S Smith; E Woo; S A Hawkins; J H Millar
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

6.  Alteration of CD1 expression in multiple sclerosis.

Authors:  S Bine; A Haziot; I Malikova; J Pelletier; D Charron; J Boucraut; N Mooney; C Gelin
Journal:  Clin Exp Immunol       Date:  2012-07       Impact factor: 4.330

7.  Omega-3 fatty acids and multiple sclerosis: relationship to depression.

Authors:  Robin L Aupperle; Douglas R Denney; Sharon G Lynch; Susan E Carlson; Debra K Sullivan
Journal:  J Behav Med       Date:  2008-04

8.  Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients.

Authors:  M I Hunter; B C Nlemadim; D L Davidson
Journal:  Neurochem Res       Date:  1985-12       Impact factor: 3.996

9.  Membrane saturated fatty acids and disease progression in multiple sclerosis patients.

Authors:  G M Hon; M S Hassan; S J van Rensburg; S Abel; R T Erasmus; T Matsha
Journal:  Metab Brain Dis       Date:  2009-11-05       Impact factor: 3.584

10.  Red blood cell membrane fluidity in the etiology of multiple sclerosis.

Authors:  Gloudina M Hon; Mogamat S Hassan; Susan J van Rensburg; Stefan Abel; Paul van Jaarsveld; Rajiv T Erasmus; Tandi Matsha
Journal:  J Membr Biol       Date:  2009-11-14       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.